---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-002622"
form_type: "8-K"
ticker: "ORKA"
cik: "0000907654"
company_name: "Oruka Therapeutics, Inc."
filed_at: "2023-02-13T23:59:59+00:00"
generated_at: "2026-06-19T17:12:28.721634+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# ARCA biopharma General Counsel Christopher Ozeroff to depart effective March 31, 2023

## Summary
- Christopher D. Ozeroff, Secretary, SVP and General Counsel, to leave ARCA biopharma effective March 31, 2023.
- Departure is mutual and not due to any disagreement with the company's operations or policies.
- Will receive severance payments and COBRA reimbursement under existing employment agreement, conditioned on release of claims.
- No replacement for General Counsel has been announced.

## SEC filing metadata
- accession: 0000950170-23-002622
- form_type: 8-K
- ticker: ORKA
- cik: 0000907654
- company_name: Oruka Therapeutics, Inc.
- filed_at: 2023-02-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/907654/000095017023002622/0000950170-23-002622-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/907654/000095017023002622/abio-20230210.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-002622
- JSON: https://secwatch.observer/filing/0000950170-23-002622.json
- Plain text: https://secwatch.observer/filing/0000950170-23-002622.txt

## Key facts
- Executive change
  Christopher D. Ozeroff departed as Secretary, Senior Vice President and General Counsel at Oruka Therapeutics, Inc..
  - Action: mutually agreed to conclude employment
  - Role: Secretary, Senior Vice President and General Counsel
  source text: ARCA biopharma, Inc. (“ARCA” or the "Company") and Christopher D. Ozeroff, the Secretary, Senior Vice President and General Counsel of ARCA have mutually agreed to conclude Mr. Ozeroff’s employment effective March 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/907654/000095017023002622/0000950170-23-002622-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.